Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy

Background/Aim: Serum tumor markers such as carcinoembryonic antigen and cytokeratin subunit 19 fragment are generally monitored in non-small cell lung cancer (NSCLC) patients in the clinical practice. However, their clinical relevance in stage III NSCLC treated with concurrent chemoradiotherapy (CC...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:In Vivo
Main Authors: TOKITO, TAKAAKI, AZUMA, KOICHI, YAMADA, KAZUHIKO, NAITO, YOSHIKO, MATSUO, NORIKAZU, ISHII, HIDENOBU, NATORI, HIROKI, KINOSHITA, TAKASHI, HOSHINO, TOMOAKI
Format: Artigo
Jezik:Inglês
Izdano: International Institute of Anticancer Research 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6559885/
https://ncbi.nlm.nih.gov/pubmed/31028213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11555
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki